As of 2024-12-13, the Relative Valuation of Karo Pharma AB (KARO.ST) is (2.53) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 60.30 SEK, the upside of Karo Pharma AB based on Relative Valuation is -104.2%.
The range of the Relative Valuation is (6.74) - 3.76 SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 16.0x | 12.4x |
| Forward P/E multiples | 14.0x - 16.0x | 15.3x |
| Fair Price | (6.74) - 3.76 | (2.53) |
| Upside | -111.2% - -93.8% | -104.2% |
| Date | P/E |